2018
1. Kawabata T, Otsuka T, Fujita K, Sakai G, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
(-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts: attenuation of p38 MAP kinase.
Int. J. Mol. Med. 2018;42:3149-3156.
2. Tokuda H, Kuroyanagi G, Onuma T, Enomoto Y, Doi T, Iida H, Otsuka T, Ogura S, Iwama T, Kojima K and Kozawa O.
Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: anti-platelet agent-effect on the release.
Biomed. Rep. 2018;8:365-372.
3. Fujita K, Otsuka T, Kawabata T, Sakai G, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
Inhibitors of heat shock protein 90 (HSP90; HSPC) augment endothelin-1-induced heat shock protein 27 (HSP27; HSPB1) through SAPK/JNK in osteoblasts.
Mol. Med. Rep. 2018;17:8542-8547.
4. Sakai G, Tokuda H, Yamamoto N, Matsushima-Nishiwaki R, Fujita K, Kawabata T, Kozawa O and Otsuka T.
Association of HSP22 with mTOR in osteoblasts: regulation of TNF-α-stimulated IL-6 synthesis.
FEBS Lett. 2018;592:1202-1210.
5. Fujita K, Otsuka T, Kawabata T, Kainuma S, Sakai G, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
HSP90 limits thrombin-stimulated IL-6 synthesis in osteoblasts: regulation of p38 MAPK.
Int. J. Mol. Med. 2018;42:2185-2192.
6. Kawabata T, Tokuda H, Sakai G, Fujita K, Matsushima-Nishiwaki R, Otsuka T and Kozawa O.
Repression of IGF-I-induced osteoblast migration by (-)- epigallocatechin gallate through p44/p42 MAP kinase.
Biomed. Rep. 2018;9:318-326.
7. Uematsu K, Enomoto Y, Onuma T, Tsujimoto M, Doi T, Matsushima-Nishiwaki R, Tokuda H, Ogura S, Iida H, Kozawa O, and Iwama T.
Rac regulates the TRAP-induced release of phosphorylated-HSP27 from human platelets via p38 MAP kinase but not JNK.
Cell. Physiol. Biochem. 2018;49:1523-1538.
8. Kawabata T, Tokuda H, Sakai G, Fujita K, Matsushima-Nishiwaki R, Kuroyanagi G, Otsuka T and Kozawa O.
HSP70 inhibitor suppresses IGF-I-stimulated migration of osteoblasts through p44/p42 MAP kinase.
Biomedicines. 2018;6:E109.
9. Matsushima-Nishiwaki R, Yamada N, Fukuchi K and Kozawa O.
Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2.
PLoS One. 2018;13:e0209050.
10. Kawabata T, Otsuka T, Fujita K, Sakai G, Kim W, Matsushima-Nishiwaki R, Kuroyanagi G, Kozawa O and Tokuda H.
HSP70 inhibitors reduce the osteoblast migration by epidermal growth factor.
Curr. Mol. Med. 2018;18:486-495.
(-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts: attenuation of p38 MAP kinase.
Int. J. Mol. Med. 2018;42:3149-3156.
2. Tokuda H, Kuroyanagi G, Onuma T, Enomoto Y, Doi T, Iida H, Otsuka T, Ogura S, Iwama T, Kojima K and Kozawa O.
Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: anti-platelet agent-effect on the release.
Biomed. Rep. 2018;8:365-372.
3. Fujita K, Otsuka T, Kawabata T, Sakai G, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
Inhibitors of heat shock protein 90 (HSP90; HSPC) augment endothelin-1-induced heat shock protein 27 (HSP27; HSPB1) through SAPK/JNK in osteoblasts.
Mol. Med. Rep. 2018;17:8542-8547.
4. Sakai G, Tokuda H, Yamamoto N, Matsushima-Nishiwaki R, Fujita K, Kawabata T, Kozawa O and Otsuka T.
Association of HSP22 with mTOR in osteoblasts: regulation of TNF-α-stimulated IL-6 synthesis.
FEBS Lett. 2018;592:1202-1210.
5. Fujita K, Otsuka T, Kawabata T, Kainuma S, Sakai G, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
HSP90 limits thrombin-stimulated IL-6 synthesis in osteoblasts: regulation of p38 MAPK.
Int. J. Mol. Med. 2018;42:2185-2192.
6. Kawabata T, Tokuda H, Sakai G, Fujita K, Matsushima-Nishiwaki R, Otsuka T and Kozawa O.
Repression of IGF-I-induced osteoblast migration by (-)- epigallocatechin gallate through p44/p42 MAP kinase.
Biomed. Rep. 2018;9:318-326.
7. Uematsu K, Enomoto Y, Onuma T, Tsujimoto M, Doi T, Matsushima-Nishiwaki R, Tokuda H, Ogura S, Iida H, Kozawa O, and Iwama T.
Rac regulates the TRAP-induced release of phosphorylated-HSP27 from human platelets via p38 MAP kinase but not JNK.
Cell. Physiol. Biochem. 2018;49:1523-1538.
8. Kawabata T, Tokuda H, Sakai G, Fujita K, Matsushima-Nishiwaki R, Kuroyanagi G, Otsuka T and Kozawa O.
HSP70 inhibitor suppresses IGF-I-stimulated migration of osteoblasts through p44/p42 MAP kinase.
Biomedicines. 2018;6:E109.
9. Matsushima-Nishiwaki R, Yamada N, Fukuchi K and Kozawa O.
Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2.
PLoS One. 2018;13:e0209050.
10. Kawabata T, Otsuka T, Fujita K, Sakai G, Kim W, Matsushima-Nishiwaki R, Kuroyanagi G, Kozawa O and Tokuda H.
HSP70 inhibitors reduce the osteoblast migration by epidermal growth factor.
Curr. Mol. Med. 2018;18:486-495.